Monday, April 20, 2015

Novartis solid tumor 'CAR T cell' still holds promise: researcher - Reuters


Reuters

Novartis solid tumor 'CAR T cell' still holds promise: researcher
Reuters
(Reuters) - A new type of immuno-oncology treatment from Novartis AG proved safe in a tiny study of three types of solid tumors, but the trial included too few patients and used too small a dose of the experimental product to prove effectiveness, according to ...
Biotech Bad News Is ContagiousWall Street Journal (blog)
Juno Therapeutics (JUNO) Stock Falls Today on Mediocre Solid Tumor Therapy ...TheStreet.com
Juno stock drops on report of lackluster immunotherapy results on solid tumorsPuget Sound Business Journal (Seattle) (blog)
Benzinga -FierceBiotech
all 10 news articles »

http://ift.tt/1HN5c0J
by via Health - Google News

No comments:

Post a Comment

Medicalia.org

Medicalia.org
developed by Internet Medical Society